Drug Shortage Report for APO-PRAVASTATIN

Last updated on 2017-08-25 History
Report ID 444
Drug Identification Number 02243508
Brand name APO-PRAVASTATIN
Common or Proper name PRAVASTATIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-31
Estimated end date 2017-09-05
Actual end date 2017-08-24
Shortage status Resolved
Updated date 2017-08-25
Company comments 500 btl available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2017-08-25 English Compare
v18 2017-08-24 French Compare
v17 2017-08-24 English Compare
v16 2017-08-24 French Compare
v15 2017-08-24 English Compare
v14 2017-08-14 French Compare
v13 2017-08-14 English Compare
v12 2017-08-08 French Compare
v11 2017-08-08 English Compare
v10 2017-08-01 French Compare
v9 2017-08-01 English Compare
v8 2017-07-31 French Compare
v7 2017-07-31 English Compare
v6 2017-04-28 French Compare
v5 2017-04-28 English Compare
v4 2017-04-24 French Compare
v3 2017-04-24 English Compare
v2 2017-03-11 French Compare
v1 2017-03-11 English Compare

Showing 1 to 19 of 19